Intermediate-term outcomes after aortic valve replacement with a novel RESILIATM tissue bioprosthesis | Zendy

Krzysztof Bartuś | Zendy; Radosław Litwinowicz | Zendy; Agata Bilewska | Zendy; Maciej Stąpór | Zendy; Maciej Bochenek | Zendy; Jacek Różański | Zendy; Jerzy Sadowski | Zendy; Grzegorz Filip | Zendy; Bogusław Kapelak | Zendy; Mariusz Kuśmierczyk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intermediate-term outcomes after aortic valve replacement with a novel RESILIATM tissue bioprosthesis

Author(s) -

Krzysztof Bartuś,

Radosław Litwinowicz,

Agata Bilewska,

Maciej Stąpór,

Maciej Bochenek,

Jacek Różański,

Jerzy Sadowski,

Grzegorz Filip,

Bogusław Kapelak,

Mariusz Kuśmierczyk

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2019.07.33

Subject(s) - medicine , calcification , aortic valve replacement , aortic valve , cardiology , hemodynamics , observational study , surgery , stenosis

The durability of bioprosthetic heart valves is limited by structural valve deterioration (SVD) due to long-term calcification. A novel bioprosthetic tissue (RESILIA TM ) has been developed which, in preclinical studies, has shown reduced calcification. The purpose of this study was to evaluate the intermediate-term clinical outcomes and hemodynamic performance of this tissue.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research